Macquarie Research

Boston Beer Company Inc (NYSE: SAM), the parent company of Sam Adams, reached an agreement to acquire Dogfish Head Brewery. This could prove to be "trophy material," according to Macquarie Research. The Analyst Macquarie analysts maintain a Neutral rating on Boston Beer with a price...

Constellation Brands, Inc. (NYSE: STZ) reported fourth-quarter results that came in better than expected. The company also announced an agreement to divest around 30 of its wine and spirits brands and related facilities for $1.7 billion. The Analysts Bank of America's Bryan Spillane maintains...

Alcohol company Constellation Brands, Inc. (NYSE: STZ) reached an agreement Wednesday to sell around 30 brands from its wine and spirits portfolio. What Happened Constellation Brands, perhaps best known for its Corona beer, will divest more than two dozen brands that retail for $11 and below,...

The market woke up Thursday to energetic interest in Monster Beverage Corporation (NASDAQ: MNST), which was surging after posting better-than-expected top-line results. Monster reported 15.8-percent organic sales growth in the fourth quarter, and its earnings per share of 43 cents beat...

Consumer products giant Procter & Gamble Co (NYSE: PG)'s presentation last week at the Consumer Analyst Group of New York conference prompted Macquarie Research to become incrementally bullish on the stock. The Analyst Analyst Caroline Levy maintained an Outperform rating on...

Boston Beer Company Inc (NYSE: SAM) is toasting a fourth-quarter bottom-line beat despite a top-line miss. The acheivement led one bear on the Street to upgrade the stock.  The Analyst  Macquarie Research analyst Caroline Levy upgraded Boston Beer from Underperform to Neutral and...

Some on the Street saw wisdom in Constellation Brands, Inc. (NYSE: STZ)'s cannabis play. But on Wednesday, when management guided for a 10-cent quarterly earnings hit from its Canopy Growth Corp. (NYSE: CGC) investment, investors second-guessed the strategy. The Rating Macquarie Research...

PepsiCo, Inc. (NASDAQ: PEP), under the leadership of new CEO Ramon Laguarta, is well-positioned to deliver sustainable 4-6-percent sales growth, according to Macquarie. The Analyst Analyst Caroline Levy upgraded PepsiCo from Neutral to Outperform with a price target lifted from $107 to $126....

Estee Lauder Companies Inc (NYSE: EL) is having a strong week after reporting a second-quarter earnings beat Tuesday. The Sell-Side Reacts  ◘ Although the company reported weak third-quarter and 2019 earnings guidance, Raymond James analyst Joseph Altobello reiterated an Outperform rating...

Younger alcohol drinkers are more health-conscious and want less sugar, alcohol and calories in their brews. At the same time, they want more choices, including hard seltzer waters and no-calorie beverages. These were some of the key takeaways for Macquarie Research from Harry Schuhmacher’s...

Cannabis company Canopy Growth Corp (NYSE: CGC) — and by default its investment partner Constellation Brands, Inc. (NYSE: STZ) — are positioning themselves to be "all things to all people" in the cannabis market, according to Macquarie Research. Canopy is also positioning...

Coca-Cola Co (NYSE: KO)'s minority investment in sports drinks maker BodyArmor is a win-win scenario for both parties, according to Macquarie Research. The Analyst Analyst Caroline Levy maintained a Neutral rating on Coca-Cola with a 12-month price target of $50. (See Levy's track record...

Constellation Brands Inc. (NYSE: STZ) invested $4 billion in the cannabis company Canopy Growth Corp (NYSE: CGC) in August for a 38-percent stake in the company — and that move earned the beverage company a sell-side downgrade Thursday.  The Analyst Macquarie Research analyst Caroline...

The beer industry is facing challenging times as production volume stagnates. U.S. beer sales volume was down 1 percent in 2017, according to statistics from the Brewers Association. Craft beer, which accounted for about 8 percent of overall dollar sales, saw sales volume rise by 5 percent....

Shares of Anheuser Busch Inbev (NYSE: BUD) fell Thursday following the company’s third-quarter earnings release and decision to cut its dividend in half to compensate for rising debt. The Analysts Bank of America analyst Paul Steegers reiterated an Underperform rating and a price...